BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 4374747)

  • 1. [Methodology of epidemiological studies in drug hepatotoxicity].
    Plomteux G
    Sem Hop; 1974 Jun; 50(28):1947-52. PubMed ID: 4374747
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic drug reactions.
    Perez V; Schaffner F; Popper H
    Prog Liver Dis; 1972; 4():597-625. PubMed ID: 4569012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug-induced liver lesions].
    Haas P
    Hippokrates; 1970 Sep; 41(3):378-84. PubMed ID: 5473617
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatotoxicity].
    Thaler H
    Dtsch Med Wochenschr; 1979 Nov; 104(46):1642-8. PubMed ID: 387369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug-induced liver disease].
    Adachi Y; Mifuji R
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():89-93. PubMed ID: 18072340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug induced hepatitis].
    Dugal JP
    Laval Med; 1968 Sep; 39(7):587-9. PubMed ID: 5744728
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrahepatic cholestasis with jaundice after taking contraceptive steroids.
    von Oldershausen HF; Eggstein M; Dold U; Knörr K
    Ger Med Mon; 1966 Jan; 11(1):24-8. PubMed ID: 5933450
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced liver injury.
    Kaplowitz N
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S44-8. PubMed ID: 14986274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Jaundice. I. Physiology of bile pigments. II. Physiopathology of jaundice].
    Jinich H
    Gac Med Mex; 1970 May; 100(5):457-86. PubMed ID: 4931406
    [No Abstract]   [Full Text] [Related]  

  • 10. Postoperative jaundice. Mechanism, diagnosis and treatment.
    Van Thiel DH; Lester R
    Surg Clin North Am; 1975 Apr; 55(2):409-18. PubMed ID: 1093267
    [No Abstract]   [Full Text] [Related]  

  • 11. An algorithm for monitoring and managing drug hepatotoxicity.
    Hofmann AF; Thistle JL
    Gastroenterology; 1974 Aug; 67(2):309-13. PubMed ID: 4847711
    [No Abstract]   [Full Text] [Related]  

  • 12. Indicators of drug abuse--hepatitis.
    Alexander M
    NIDA Res Monogr; 1977 Mar; (10):123-9. PubMed ID: 405593
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatotoxicity of drugs. Interactions, mechanisms and prediction].
    Berthelot P
    Actual Pharmacol (Paris); 1974; 27():145-63. PubMed ID: 4620126
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced liver disease: an overview.
    Zimmerman HJ
    Semin Liver Dis; 1981 May; 1(2):93-103. PubMed ID: 7051299
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced hepatitis].
    Dem'ianenko SM
    Vrach Delo; 1989 Dec; (12):64-6. PubMed ID: 2629281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased quality of life--your patient does not tolerate his medication?].
    Bischoff A
    MMW Fortschr Med; 2004 May; 146(21):10. PubMed ID: 15373075
    [No Abstract]   [Full Text] [Related]  

  • 17. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On drug-induced hepatitis].
    Lemaire A; Cloarec M; Ung Poleng
    Therapie; 1969; 24(1):51-9. PubMed ID: 5807422
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatobiliary complications of sepsis.
    Ledgerwood A
    Heart Lung; 1976; 5(4):621-3. PubMed ID: 1047057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-A, non-B hepatitis in hemodialysis patients: medicamentous etiology].
    Simon P; Meyrier A; Menault M; Bombail D
    Nouv Presse Med; 1979 Mar; 8(14):1186. PubMed ID: 461151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.